Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases

Abstract Nitric oxide (NO) has been known to promote physiological angiogenesis to treat peripheral arterial diseases (PAD) by increasing the vascular endothelial growth factor (VEGF) level in endothelial cells (ECs) and preventing platelet adherence and leukocyte chemotaxis. However, the ongoing is...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Duong Q. Le, Aneetta E. Kuriakose, Dat X. Nguyen, Kytai T. Nguyen, Suchismita Acharya
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7637cfe3fade4f56961d82fc45717686
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!